Astrana Health Inc (ASTH) valuation · P/E 45, rev $3.18B
Astrana Health Inc (ASTH) P/E 45, rev $3.18B.
| Metric | Value |
|---|---|
| P/E | 45 |
| Market cap | $1.13B |
| Revenue | $3.18B |
| P/S | 0.4 |
ASTH valuation FAQ
What is ASTH's P/E ratio?
Astrana Health Inc (ASTH) trailing P/E is 45 on the latest cached fundamentals snapshot.
What is ASTH's market cap?
Astrana Health Inc (ASTH) market cap is $1.13B on the latest cached fundamentals snapshot.
What is ASTH's latest revenue?
Latest cached Astrana Health Inc (ASTH) revenue was $3.18B. Statements: https://lician.com/financials/asth
What is ASTH's price-to-sales ratio?
Astrana Health Inc (ASTH) price-to-sales (P/S) is 0.4, cached market cap $1.13B divided by revenue $3.18B.
How many ASTH valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Astrana Health Inc (ASTH): P/E, Market cap, Revenue, and P/S.
Where is ASTH valuation listed?
Cached valuation multiples for Astrana Health Inc (ASTH) are listed at https://lician.com/valuation/asth.
Not investment advice. Cached rows, not a live tape.